AXQ Capital LP Sells 33,177 Shares of Option Care Health, Inc. $OPCH

AXQ Capital LP trimmed its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 82.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,915 shares of the company’s stock after selling 33,177 shares during the quarter. AXQ Capital LP’s holdings in Option Care Health were worth $220,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in OPCH. Royal Bank of Canada grew its stake in shares of Option Care Health by 20.7% during the 1st quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock worth $8,078,000 after acquiring an additional 39,661 shares in the last quarter. AQR Capital Management LLC boosted its holdings in shares of Option Care Health by 162.6% in the 1st quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock valued at $1,450,000 after buying an additional 25,777 shares during the last quarter. Empowered Funds LLC acquired a new stake in shares of Option Care Health in the 1st quarter valued at approximately $208,000. Invesco Ltd. boosted its holdings in shares of Option Care Health by 2.7% in the 2nd quarter. Invesco Ltd. now owns 294,363 shares of the company’s stock valued at $9,561,000 after buying an additional 7,678 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Option Care Health by 528.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after buying an additional 1,183 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, CEO John Charles Rademacher purchased 12,500 shares of the business’s stock in a transaction on Monday, May 4th. The stock was acquired at an average price of $21.18 per share, with a total value of $264,750.00. Following the acquisition, the chief executive officer directly owned 695,152 shares of the company’s stock, valued at $14,723,319.36. This trade represents a 1.83% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Timothy P. Sullivan purchased 24,154 shares of the business’s stock in a transaction on Thursday, May 7th. The shares were acquired at an average cost of $20.69 per share, with a total value of $499,746.26. Following the acquisition, the director directly owned 73,383 shares in the company, valued at approximately $1,518,294.27. The trade was a 49.06% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired 73,264 shares of company stock valued at $1,548,316 in the last quarter. 1.70% of the stock is currently owned by insiders.

Option Care Health Trading Up 2.2%

Shares of Option Care Health stock opened at $20.51 on Friday. The business has a fifty day simple moving average of $24.32 and a two-hundred day simple moving average of $29.53. Option Care Health, Inc. has a 1 year low of $18.01 and a 1 year high of $36.80. The company has a market capitalization of $3.22 billion, a price-to-earnings ratio of 15.90, a P/E/G ratio of 1.14 and a beta of 0.67. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. During the same quarter last year, the firm posted $0.40 EPS. The company’s quarterly revenue was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Research analysts forecast that Option Care Health, Inc. will post 1.64 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently commented on OPCH. Morgan Stanley set a $28.00 price objective on Option Care Health in a report on Wednesday, May 6th. Barrington Research cut their price objective on Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Weiss Ratings downgraded Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Stephens set a $30.00 price objective on Option Care Health in a report on Friday, May 1st. Finally, JPMorgan Chase & Co. cut their price objective on Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $31.25.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.